Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Botulinum toxin is used for neck, shoulder, calf, and ankle slimming, and hair loss treatment, but can cause muscle weakness and atrophy with regular use.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Chromosomal differences affect how muscle cells respond to testosterone.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Cold-pressed rapeseed oil is most resistant to oxidation and certain oils may reduce chronic disease risk; consumers like the taste of pumpkin oil best.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

More personalized and effective treatments for androgenetic alopecia are needed.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Topical minoxidil showed promise for early male pattern baldness.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.